Skip to Content

Leuprolide Acetate 14-Day Kit

Last Updated: July 20, 2018
Status: Current

Products Affected - Description
    • Leuprolide Acetate injection, Sandoz, 1 mg/0.2 mL, 2.8 mL multiple dose vial, 14 day kit NDC 00781-4003-32
    • Leuprolide Acetate injection, Sun Pharma, 1 mg/0.2 mL, 2.8 mL multiple dose vial, 14 day kit NDC 47335-0936-40
    • Leuprolide Acetate injection, Teva, 1 mg/0.2 mL, 2.8 mL multiple dose vial, 14 day kit NDC 00703-4014-18
Reason for the Shortage
    • Sun Pharma did not provide a reason for the shortage.
    • Sandoz states the reason for the shortage was increased demand.
    • Teva states the shortage is due to manufacturing delays.
Available Products
    • There is insufficient supply for usual ordering

Estimated Resupply Dates

    • Sandoz has leuprolide acetate injection on intermittent back order and the company is releasing product as it becomes available.
    • Teva has leuprolide acetate injection on long-term back order and the company cannot estimate a release date.
    • Sun Pharma has leuprolide acetate injection on back order and the company cannot estimate a release date.

Updated

Updated July 20, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. Created February 25, 2011 by Jane Chandramouli, PharmD, Drug Information Specialist. Copyright 2018, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide